SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001663577-22-000314
Filing Date
2022-05-18
Accepted
2022-05-18 12:27:48
Documents
13
Period of Report
2022-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 abti8k.htm   iXBRL 8-K 24445
2 ex99_1.htm EX-99.1 9146
  Complete submission text file 0001663577-22-000314.txt   203309

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abti-20220517.xsd EX-101.SCH 2974
4 XBRL LABEL FILE abti-20220517_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE abti-20220517_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT abti8k_htm.xml XML 3168
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

IRS No.: 821317032 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 333-156091 | Film No.: 22937823
SIC: 2833 Medicinal Chemicals & Botanical Products